Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-14

Clinical Trial Update: MINDFUL-OBOT: Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment [NA]

View source ↗

Summary

A completed clinical trial evaluating whether mindfulness training reduces opioid use and anxiety in people receiving buprenorphine for opioid-use disorder. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: Cambridge Health Alliance | Conditions: Opioid-use Disorder, Anxiety | NA | Status: COMPLETED